Kidney transplant outcomes associated with the use of increased risk donors in children

被引:14
作者
Kizilbash, Sarah J. [1 ]
Rheault, Michelle N. [1 ]
Wang, Qi [2 ]
Vock, David M. [3 ]
Chinnakotla, Srinath [4 ]
Pruett, Tim [4 ]
Chavers, Blanche M. [1 ]
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Clin & Translat Sci Inst, Biostat Design & Anal Ctr, Minneapolis, MN USA
[3] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[4] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA
关键词
clinical research; practice; donors and donation; deceased; donor-derived infections; kidney transplantation; nephrology; FOR-DISEASE-CONTROL; UNITED-STATES; INFECTION; TIME; HIV; TRANSMISSION; RECIPIENTS; IMPACT; RATES;
D O I
10.1111/ajt.15231
中图分类号
R61 [外科手术学];
学科分类号
摘要
Increased risk donors (IRDs) may inadvertently transmit blood-borne viruses to organ recipients through transplant. Rates of IRD kidney transplants in children and the associated outcomes are unknown. We used the Scientific Registry of Transplant Recipients to identify pediatric deceased donor kidney transplants that were performed in the United States between January 1, 2005 and December 31, 2015. We used the Cox regression analysis to compare patient and graft survival between IRD and non-IRD recipients, and a sequential Cox approach to evaluate survival benefit after IRD transplants compared with remaining on the waitlist and never accepting an IRD kidney. We studied 328 recipients with and 4850 without IRD transplants. The annual IRD transplant rates ranged from 3.4% to 13.2%. IRDs were more likely to be male (P = .04), black (P < .001), and die from head trauma (P = .006). IRD recipients had higher mean cPRA (0.085 vs 0.065, P = .02). After multivariate adjustment, patient survival after IRD transplants was significantly higher compared with remaining on the waitlist (adjusted hazard ratio [aHR]: 0.48, 95% CI: 0.26-0.88, P = .018); however, patient (aHR: 0.93, 95% CI: 0.54-1.59, P = .79) and graft survival (aHR: 0.89, 95% CI: 0.70-1.13, P = .32) were similar between IRD and non-IRD recipients. We recommend that IRDs be considered for transplant in children.
引用
收藏
页码:1684 / 1692
页数:9
相关论文
共 33 条
[1]   Probability of deceased donor kidney transplantation based on % PRA [J].
Bostock, I. C. ;
Alberu, J. ;
Arvizu, A. ;
Hernandez-Mendez, E. A. ;
De-Santiago, A. ;
Gonzalez-Tableros, N. ;
Lopez, M. ;
Castelan, N. ;
Contreras, A. G. ;
Morales-Buenrostro, L. E. ;
Gabilondo, B. ;
Vilatoba, M. .
TRANSPLANT IMMUNOLOGY, 2013, 28 (04) :154-158
[2]   Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys [J].
Bowring, Mary G. ;
Holscher, Courtenay M. ;
Zhou, Sheng ;
Massie, Allan B. ;
Garonzik-Wang, Jacqueline ;
Kucirka, Lauren M. ;
Gentry, Sommer E. ;
Segev, Dorry L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (03) :617-624
[3]   One-Year Mortality Rates in US Children with End-Stage Renal Disease [J].
Chavers, Blanche M. ;
Molony, Julia T. ;
Solid, Craig A. ;
Rheault, Michelle N. ;
Collins, Allan J. .
AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (02) :121-128
[4]   Identifying Appropriate Recipients for CDC Infectious Risk Donor Kidneys [J].
Chow, E. K. H. ;
Massie, A. B. ;
Muzaale, A. D. ;
Singer, A. L. ;
Kucirka, L. M. ;
Montgomery, R. A. ;
Lehmann, H. P. ;
Segev, D. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (05) :1227-1234
[5]   Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient [J].
Chute, Donald F. ;
Chung, Raymond T. ;
Sise, Meghan E. .
KIDNEY INTERNATIONAL, 2018, 93 (03) :560-567
[6]   Centers for Disease Control 'High-Risk' Donors and Kidney Utilization [J].
Duan, K. I. ;
Englesbe, M. J. ;
Volk, M. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (02) :416-420
[7]   Transplantation of Center for Disease Control "High-Risk" Donor Hearts Does Not Adversely Impact Long-Term Outcomes in Adults [J].
Gaffey, Ann C. ;
Cucchiara, Andrew J. ;
Goldberg, Lee R. ;
Blumberg, Emily A. ;
Acker, Michael A. ;
Atluri, Pavan .
JOURNAL OF CARDIAC FAILURE, 2016, 22 (05) :376-382
[8]   The 'blood group O problem' in kidney transplantation-time to change? [J].
Glander, Petra ;
Budde, Klemens ;
Schmidt, Danilo ;
Fuller, T. Florian ;
Giessing, Markus ;
Neumayer, Hans-Hellmut ;
Liefeldt, Lutz .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (06) :1998-2004
[9]   Education and informed consent about increased risk donor kidneys: a national survey of non-physician transplant providers [J].
Gordon, E. J. ;
Mullee, J. ;
Beauvais, N. ;
Warren, E. ;
Theodoropoulos, N. ;
McNatt, G. ;
Rassiwala, J. ;
Ison, M. G. .
TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) :251-260
[10]   Kidney transplant candidates' understanding of increased risk donor kidneys: a qualitative study [J].
Gordon, Elisa J. ;
Reddy, Elizabeth ;
Ladner, Daniela P. ;
Friedewald, John ;
Abecassis, Michael M. ;
Ison, Michael G. .
CLINICAL TRANSPLANTATION, 2012, 26 (02) :359-368